The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PCA SKIN Introduces Targeted Neuropeptide Clinically Proven to Improve Expression Lines

Article-PCA SKIN Introduces Targeted Neuropeptide Clinically Proven to Improve Expression Lines

Sponsored by: PCA SKIN As innovators of professional-grade skin-care products for over 30 years, PCA SKIN®️ (Scottsdale, Ariz.) brings truly transformative products to the market to improve not just your patients’ skin health, but their lives too.And now, PCA SKIN will introduce their latest breakthrough innovation, ExLinea®️ Pro Peptide Serum, which launches on June 14, 2021.

Sponsored by: PCA SKIN

As innovators of professional-grade skin-care products for over 30 years, PCA SKIN®️ (Scottsdale, Ariz.) brings truly transformative products to the market to improve not just your patients’ skin health but their lives too. And now, PCA SKIN will introduce their latest breakthrough innovation, ExLinea®️ Pro Peptide Serum, which launches on June 14, 2021.

ExLinea Pro Peptide Serum is an advanced neuropeptide spot treatment that can be used alone or as a complement to your patients’ in-office aesthetic treatments. The formula features Peptide-Pro Complex, a proprietary technology that blends efficacious levels of neuropeptides, proteins, amino acids, and marine extracts to visibly reduce expression lines, lift and tighten skin, and improve epidermal thickness while increasing hydration and moisture retention.

Peptide-Pro Complex, the proprietary blend that incorporates SNAP-8™ peptide, Argireline®️ Amplified peptide, a polysaccharide-amino acid blend, and bacillus/soybean marine extract, affects nerve-to-muscle communication to reduce facial muscle con-tractions while contouring and firming skin.

Carolyn Jacob, MD, FAADCarolyn Jacob, MD, FAAD  Dermatologist Founder and Medical Director Chicago Cosmetic Surgery and Dermatology Chicago, IL

The unparalleled efficacy of this advanced serum is clinically proven. ExLinea Pro Peptide Serum was tested on 31 female participants between the ages of 35 and 55 years old with Fitzpatrick types ranging from I to III to evaluate the product’s effects on the skin when applied twice daily over 12 weeks. Immediate results showed significant lifting and tightening ten minutes after just one application. 100% of patients demonstrated a visible reduction in fine lines and wrinkles and a smoother skin texture after 12 weeks.

Carolyn Jacob, MD, a board-certified dermatologist, founder, and medical director of Chicago Cosmetic Surgery and Dermatology in Chicago, Ill., was one of the fortunate physicians to get a sneak peek of the new formula.“This is a great product for patients who are needle-phobic,” she reported.“It also works for patients who want to smooth areas not treated by neuromodulators and for anyone who wants some prerejuvenation.” She also pointed out that the product can be used for moms who are nursing and patients who are in-between injectables, making this a truly versatile product.

“ExLinea Pro Peptide Serum can be used to complement all injectables and as an adjunct to cosmetic treatments or as a stand-alone solution,” Dr. Jacob continued. And, with some patients opting to use more at-home treatments because of the recent pandemic, physicians and patients will be pleased with the clinical study data that backs the results.

efore and 12 weeks after twice a day use of ExLinea Pro Peptide Serum on the foreheadPhotos courtesy of PCA SKINToday’s aesthetic patients rely on their physicians to provide them with safe and effective skincare they can trust. With proven results and exceptional versatility, ExLinea Pro Peptide Serum by PCA SKIN will ensure high patient satisfaction.

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish